Antibiotice S.A. (BVB:ATB)

Antibiotice Revenue

Antibiotice had revenue of 142.81M RON in the quarter ending March 31, 2026, a decrease of -12.85%. This brings the company's revenue in the last twelve months to 638.98M, down -4.14% year-over-year. In the year 2025, Antibiotice had annual revenue of 660.04M, down -4.16%.

• Revenue (ttm): 638.98M
• Revenue Growth: -4.14%
• P/S Ratio: 2.11
• Revenue / Employee: 471.57K
• Employees: 1,356
• Market Cap: 1.35B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	660.04M	-28.66M	-4.16%
Dec 31, 2024	688.70M	73.41M	11.93%
Dec 31, 2023	615.29M	110.29M	21.84%
Dec 31, 2022	505.00M	126.17M	33.31%
Dec 31, 2021	378.83M	31.60M	9.10%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 7, 2026

Data Sources Report a data error